Recurrent restenosis after implantation of sirolimus-eluting stents in aorto-ostial lesions: successful treatment with polytetrafluoroethylene-covered stents

J Cardiovasc Med (Hagerstown). 2008 Feb;9(2):201-4. doi: 10.2459/JCM.0b013e3281ac22b5.

Abstract

We describe three cases of aorto-ostial lesions with recurrent restenosis after multiple modalities of percutaneous treatment, including sirolimus-eluting stent implantation in all cases and intravascular brachytherapy in one case. In-stent restenosis was successfully managed with polytetrafluoroethylene-covered stents. Six-month angiographic follow-up documented complete patency of the target segment in all patients.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Aged, 80 and over
  • Angioplasty, Balloon, Coronary
  • Coronary Artery Disease / therapy*
  • Coronary Restenosis / prevention & control
  • Coronary Restenosis / therapy*
  • Drug-Eluting Stents*
  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Male
  • Polytetrafluoroethylene*
  • Prosthesis Design
  • Recurrence
  • Retreatment
  • Risk Assessment
  • Sirolimus / administration & dosage
  • Stents*

Substances

  • Immunosuppressive Agents
  • Polytetrafluoroethylene
  • Sirolimus